Module Details

Module Code: ZPHA C3104
Module Title: Cardiovascular Disease and Diabetes Patient Care.
Title: Cardiovascular Disease and Diabetes Patient Care.
Module Level:: 7
Credits:: 10
Module Coordinator: Paula Rankin
Module Author:: Paula Rankin
Domains:  
Module Description: To provide students with the knowledge, skills and competencies required to deliver safe and effective pharmacy services to people with cardiovascular disease and / or diabetes and optimise patient outcomes.
 
Learning Outcomes
On successful completion of this module the learner will be able to:
# Learning Outcome Description
LO1 Describe and explain the causes and underlying patho-physiology of diabetes and cardiovascular disease and the challenges these conditions present to patients and the pharmacy team.
LO2 Identify and appraise medicines and devices used in the management of diabetes and cardiovascular disease, in order to deal with basic medicine information queries, drug-drug interactions and recognise evidence-based prescribing. Review and dispense prescriptions under supervision in accordance with legislation, in either a community pharmacy or hospital dispensary.
LO3 Advise patients and their carers on non-pharmacological measures essential for the management of diabetes and cardiovascular disease, and organise and conduct a range of services covering both primary and secondary prevention of cardiovascular disease and diabetes in compliance with best practice guidelines.
LO4 Describe and apply a range of communication techniques, including consultation skills, coaching skills and motivational interviewing. Evaluate the effectiveness of these technicques in a range of pharmacy settings, to optimise medicine use and patient outcomes.
Dependencies
Module Recommendations

This is prior learning (or a practical skill) that is recommended before enrolment in this module.

No recommendations listed
Co-requisite Modules
No Co-requisite modules listed
Additional Requisite Information
No Co Requisites listed
 
Indicative Content
Cardiovascular disease.
Signs, symptoms, risk factors, diagnosis and management (pharmacological & non-pharmacological) of a range of common cardiovascular conditions including hypertension, dyslipidaemias, clotting disorders, ischaemic heart disease, heart failure, stroke, myocardial infarction and atrial fibriliation. Medicine management strategies.
Diabetes
Including but not limited to the signs, symptoms, risk factors and management of type 1, type 2 and gestational diabetes. Sick day rules. Minimising short and long term complications of diabetes.
Health Promotion
Identifying and managing risk factors for cardiovascular disease and diabetes. In terms of lifestyle modifications, there is a strong emphasis on diet and exercise (Smoking is covered in respiratory module). Screening services. Strategies to improve adherence.
Module Content & Assessment
Assessment Breakdown%
Continuous Assessment40.00%
Practical20.00%
End of Module Formal Examination40.00%

Assessments

Full Time

Continuous Assessment
Assessment Type Other % of Total Mark 40
Timing Every Week Learning Outcomes 1,2,3,4
Non-marked No
Assessment Description
Continuous assessment will include strategies to encourage engagement with on-line resources. These will include quizzes, participation in class discussions (both face to face and via Blackboard) and the use of on-line reflective diaries.
Continuous assessment will also include review of case studies, completion of practical work sheets. Students will be required to demonstrate mastery of a range of practical skills (as well as theoretical knowledge) during practical classes.
No Project
Practical
Assessment Type Practical/Skills Evaluation % of Total Mark 20
Timing n/a Learning Outcomes 1,2
Non-marked No
Assessment Description
n/a
End of Module Formal Examination
Assessment Type Formal Exam % of Total Mark 40
Timing End-of-Semester Learning Outcomes 1,2,3,4
Non-marked No
Assessment Description
Formal exam

Part Time

Continuous Assessment
Assessment Type Other % of Total Mark 40
Timing Every Week Learning Outcomes 1,2,3,4
Non-marked No
Assessment Description
Continuous assessment will include strategies to encourage engagement with on-line resources. These will include quizzes, participation in class discussions (both face to face and via Blackboard) and the use of on-line reflective diaries.
Continuous assessment will also include review of case studies, completion of practical work sheets. Students will be required to demonstrate mastery of a range of practical skills (as well as theoretical knowledge) during practical classes.
No Project
Practical
Assessment Type Practical/Skills Evaluation % of Total Mark 20
Timing n/a Learning Outcomes  
Non-marked No
Assessment Description
Practical
End of Module Formal Examination
Assessment Type Formal Exam % of Total Mark 40
Timing End-of-Semester Learning Outcomes 1,2,3,4
Non-marked No
Assessment Description
Final exam will consist of a 3 hour written exam.
Reassessment Requirement
Exam Board
It is at the discretion of the Examination Board as to what the qualifying criteria are.

SETU Carlow Campus reserves the right to alter the nature and timings of assessment

 

Module Workload

Workload: Full Time
Workload Type Workload Category Contact Type Workload Description Frequency Average Weekly Learner Workload Hours
Lecture Contact No Description 12 Weeks per Stage 3.00 36
Practicals Contact No Description 12 Weeks per Stage 1.00 12
Independent Learning Non Contact No Description 15 Weeks per Stage 13.33 200
Total Weekly Contact Hours 4.00
Workload: Part Time
Workload Type Workload Category Contact Type Workload Description Frequency Average Weekly Learner Workload Hours
Lecture Contact No Description 12 Weeks per Stage 3.00 36
Practicals Contact No Description 12 Weeks per Stage 1.00 12
Independent Learning Non Contact No Description 15 Weeks per Stage 5.13 77
Total Weekly Contact Hours 4.00
 
Module Resources
Recommended Book Resources
  • Pharmaceutical Press. BNF British National Formulary.
  • Bruce Hugman. (2009), Healthcare Communication., Pharmaceutical Press, [ISBN: 978-0-85369-7].
  • Roger Walker BPharm PhD FRPharmS FFPH (Editor), Cate Whittlesea BSc MSc PhD MRPharmS (Editor). (2012), Clinical Pharmacy and Therapeutics, 5e, 5. Churchill Livingstone, p.998, [ISBN: 9780702042935].
Supplementary Book Resources
  • Felicity J. Smith. Conducting your pharmacy practice research project, 2. London ; Pharmaceutical Press, 2010., [ISBN: 9780853698692].
This module does not have any article/paper resources
Other Resources
Discussion Note: